Bleedings from acute gastric and duodenum ulcers in clinical practice
DOI:
https://doi.org/10.62480/tjms.2024.vol39.pp52-55Keywords:
thrombocytopenia, glucocorticoids, complication, ulcer bleedingAbstract
There are presented the reasons of Sharp stomach ulcer bleeding (or intensification) duodenal ulcer or ulcer bleeding while applicating glucocorticoid hormones on patients with thrombocytopenic purpura. It is recommended to change GCH application from per os to inhalation or intravenous injection. It is proved that there is a direct connection between recommendation to endoscopic investigation and bleeding, stomach ulcer and duodenal ulcer from the quantity of thrombocytes. Ans it is also recommended to make endoscopic investigation on thrombocytopenic purpura during clinical remission
References
Abdulkadyrov KM / / The latest Hematology directory. Moscow, 2004, 358-402 p.
Mikhailov A.P, Danilov, A.M, Napalkov A.N, Shulgin V.L. / / acute ulcers and erosions digestive
tract: a training manual / / St. Petersburg.: Publisher St. Petersburg State University, 2004 - 96.
Bokarev I.N. / / hemorrhagic syndrome / / practice of medicine. - M., 2006. - 127 p.
Vakhrushev JM, S. Romanov, Klimentova SV / / Evaluation of the functional state of the stomach
during prolonged treatment with prednisone in patients with bronchial asthma / / The 7th National
Congress on Respiratory Diseases. Sat Nauchn. mp. - M., 1997. – 43p.
Mustafakulov G.I. / / Prevention of complications of the gastrointestinal tract during GC therapy in
patients with ITP / / Pathology (Tashkent). - 2006. - № 1. - 53-55 p.
Cook D.J., Fuller H.D., Guyatt G.H., et al. Risk factors for gastrointestinal bleeding in critically ill
patient: Canadian Crit.CareTrialsGroups.// N.Engl.J.Med. – 1994. – Vol. 330. – p.397-381.
Kantorova I., Svoboda P., Scheer P., et al. Stress ulcer prophylaxis in critically ill patients: a
randomized controlled trial// Hepatogastroenterology. – 2004. – V.51, №57.- p. 757-761.
Mustafakulov, G. I., & Ortiqboyev, F. D. (2023). Comprehensive approach to improving
autoimmune thrombocytopenic purpura treatment results. //Mеждународном научном журнале
«Молодой ученый»-№5 (452) февраль 2023г.
Hand-assisted laparoscopic splenectomy: indications and technique /Bermas H., Fenoglio M.E.,
Haun W., Moore J.T. // JSLS. – 2004. – vol. 8910. – P. 69-71.
Mustafakulov G. I. et al. SPLENECTOMY FOR HAIRY CELL LEUKEMIA //Central Asian
Journal of Medicine. – 2021. – Т. 2021. – №. 4. – С. 160-167.
Mustafakulov, G. I., Atakhodzgaeva M.A., Anvarkhodzaeva Sh.G. Rtsults conservative treatment of
autoimmune diseases thrombocytopenic purpura. //International Journal of Medical Sciences And
Clinical Research. – 2023. – november, 23.
Мустафакулов, Г. И., Бахромов, С. М., Эргашев, У. Ю., Атаходжаева, Ф. А., Атаходжаева, М.
А. (2021). Опыт применения ингаляций глюкокортикоидами у пациентов с иммунной
тромбоцитопенией.
Mahevas M, Guillet S, Viallard J-F, et al. Rate of Prolonged Response after Stopping
Thrombopoietin-Receptor Agonists Treatment in Primary Immune Thrombocytopenia (ITP): Results
from a Nationwide Prospective Multicenter Interventional Study (STOPAGO). Blood.
;138(Suppl 1):583. doi: 10.1182/blood-2021-152767.
18. Doobaree IU, Newland A, McDonald V, et al. Primary immune thrombocytopenia (ITP) treated
with romiplostim in routine clinical practice: retrospective study from the United
Kingdom ITP Registry. Eur J Haematol. 2019;102(5):416–23. doi: 10.1111/ejh.13221.
19. Forsythe A, Schneider J, Pham T, et al. Real-world evidence on clinical outcomes in immune
thrombocytopenia treated with thrombopoietin receptor agonists. J Comp Eff Res. 2020;9(7):447–57.
doi: 10.2217/cer-2019-0177.
Гематология и трансфузиология. 2020;65(S1):22. [Vinogradova OYu, Bobkova MM,
Chernikov MV, et al. Sustaining off-treatment remission in immune thrombocytopenia (ITP) patients
with complete stable response to thrombopoietin receptor agonists (TPO-RAs). Gematologiya i
transfuziologiya. 2020;65(S1):22. (In Russ)]
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.
